IRLAB Therapeutics AB
STO:IRLAB A

Watchlist Manager
IRLAB Therapeutics AB Logo
IRLAB Therapeutics AB
STO:IRLAB A
Watchlist
Price: 11.05 SEK -0.45%
Market Cap: 572.3m SEK
Have any thoughts about
IRLAB Therapeutics AB?
Write Note

P/S
Price to Sales

10
Current
12.3
Median
2.5
Industry
Lower than median
Higher than industry value

Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.

P/S
10
=
Market Cap
573.1m SEK
/
Revenue
57.5m SEK
All Countries
Close

P/S Forward Multiples

Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/S
4.6
2-Years Forward
P/S
1.6
3-Years Forward
P/S
6.3

See Also

Discover More